⌘K

Login Start Free

Home/Filings/4/0001209191-22-052359

4//SEC Filing

Zeronda Tyler 4

Accession 0001209191-22-052359

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 5:05 PM ET

Size

5.1 KB

Accession

0001209191-22-052359

Insider Transaction Report

Form 4

Period: 2022-09-30

VYNE Therapeutics Inc.VYNE

CHIEF FINANCIAL OFFICER

Transactions

Tax Payment
Common Stock
2022-09-30$0.22/sh−353$79→ 173,359 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001867033

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 5:05 PM ET
Size: 5.1 KB

View on SEC.gov